Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined With FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Authors

A N. Audino
S Goldman
M J. Barth
Jessica Hochberg, New York Medical CollegeFollow
A C. Xavier
B Shiramizu
Qiuhu Shi, New York Medical CollegeFollow
L Harrison
J Basso
J Oesterheld
K M. Heym
R A. Drachtman
P Harker-Murray
S L. Perkins
R R. Miles
Mitchell S. Cairo, New York Medical CollegeFollow

Author Type(s)

Faculty

Document Type

Abstract

Publication Date

11-2-2023

DOI

10.1182/blood-2023-181756

Journal Title

Blood

Department

Pediatrics

Second Department

Public Health

Recommended Citation

Audino, A. N., Goldman, S., Barth, M. J., Hochberg, J., Xavier, A. C., Shiramizu, B., Shi, Q., Harrison, L., Basso, J., Oesterheld, J., Heym, K. M., Drachtman, R. A., Harker-Murray, P., Perkins, S. L., Miles, R. R., & Cairo, M. S. (2023). Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined With FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL. Blood, 142 (Suppl. 1), 1727. https://doi.org/10.1182/blood-2023-181756